MicroRNA-7-5p Mediates the Signaling of Hepatocyte Growth Factor to Suppress Oncogenes in the MCF-10A Mammary Epithelial Cell
Affiliations
MicroRNA-7 (miR-7) is a non-coding RNA of 23-nucleotides that has been shown to act as a tumor suppressor in various cancers including breast cancer. Although there have been copious studies on the action mechanisms of miR-7, little is known about how the miR is controlled in the mammary cell. In this study, we performed a genome-wide expression analysis in miR-7-transfected MCF-10A breast cell line to explore the upstream regulators of miR-7. Analysis of the dysregulated target gene pool predicted hepatocyte growth factor (HGF) as the most plausible upstream regulator of miR-7. MiR-7 was upregulated in MCF-10A cells by HGF, and subsequently downregulated upon treatment with siRNA against HGF. However, the expression of HGF did not significantly change through either an upregulation or downregulation of miR-7 expression, suggesting that HGF acts upstream of miR-7. In addition, the target genes of miR-7, such as EGFR, KLF4, FAK, PAK1 and SET8, which are all known oncogenes, were downregulated in HGF-treated MCF-10A; in contrast, knocking down HGF recovered their expression. These results indicate that miR-7 mediates the activity of HGF to suppress oncogenic proteins, which inhibits the development of normal cells, at least MCF-10A, into cancerous cells.
Molecular mechanism of the signaling axis regulating the progression of hepatocellular carcinoma.
Zhang N, Wang F, Zhu L, Chang R, Mok S, Peixoto R Ann Transl Med. 2023; 11(1):12.
PMID: 36760243 PMC: 9906214. DOI: 10.21037/atm-22-5929.
Wang Z, Cui X, Hao G, He J Open Life Sci. 2021; 16(1):1037-1044.
PMID: 34632072 PMC: 8477673. DOI: 10.1515/biol-2021-0101.
Glucose Transporters as a Target for Anticancer Therapy.
Pliszka M, Szablewski L Cancers (Basel). 2021; 13(16).
PMID: 34439338 PMC: 8394807. DOI: 10.3390/cancers13164184.
Korac P, Antica M, Matulic M Biomedicines. 2021; 9(3).
PMID: 33806891 PMC: 8004586. DOI: 10.3390/biomedicines9030325.
P21-Activated Kinase 1: Emerging biological functions and potential therapeutic targets in Cancer.
Yao D, Li C, Rajoka M, He Z, Huang J, Wang J Theranostics. 2020; 10(21):9741-9766.
PMID: 32863957 PMC: 7449905. DOI: 10.7150/thno.46913.